REVERSE TRANSCRIPTASE INHIBITORS FOR TREATING ADENOCARCINOMAS

A reverse transcriptase inhibitor such as 3 min - azido - 3 min - deoxythymidine is used for the treatment or prophylaxis of a retrovivus-associated carcinoma such as breast cancer in a human.

Saved in:
Bibliographic Details
Main Authors MCCARTHY; KEVIN, AL-SUMIDAIE; AYAD M, GREEN; CHRISTOPHER D, LEINSTER; SAMUEL J, HART; CHARLES A
Format Patent
LanguageEnglish
Published 29.06.1993
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A reverse transcriptase inhibitor such as 3 min - azido - 3 min - deoxythymidine is used for the treatment or prophylaxis of a retrovivus-associated carcinoma such as breast cancer in a human.
Bibliography:Application Number: US19900536669